SOPHiA GENETICS announced an expanded collaboration with Result Laboratorium, a leading clinical laboratory in the Netherlands, to advance the delivery of pharmacogenomics (PGx) insights. This partnership leverages the SOPHiA DDM™ Platform and SOPHiA DDM™ Dispatch to enable scalable PGx analysis across the region.
Under this model, Result Laboratorium will function as a regional hub, centralizing sequencing and analysis for other healthcare institutions. This approach allows institutions to offer high-quality PGx insights without the need to build complex in-house infrastructure, fostering collaboration and efficiency.
The SOPHiA DDM™ Platform is built to meet stringent data safety requirements, operating in a GDPR-compliant, HIPAA-compliant, and cloud-native environment with ISO 27001:2022, ISO 27017:2015, ISO 27018:2019 certifications, and C5 attestation. This ensures consistent, high-quality insights while reducing duplication of effort and allowing participating institutions to retain control over their clinical workflows.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.